Echo Street Capital Management LLC Mirati Therapeutics, Inc. Transaction History

Echo Street Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$41.27 - $98.62 $930,019 - $2.22 Million	22,535 Added 448.01%	27,565 $1.25 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $299,285 - $436,101	5,030 New	5,030 $351,000
Q2 2022 Aug 15, 2022	SELL	$39.16 - $88.71 $218,669 - $495,356	-5,584 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $423,378 - $843,016	5,584 New	5,584 $459,000
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $660,121 - $886,540	-4,996 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $201,600 - $251,622	1,400 Added 38.93%	4,996 $807,000
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $282,083 - $393,357	-1,775 Reduced 33.05%	3,596 $616,000
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $870,370 - $1.29 Million	5,371 New	5,371 $1.18 Million
Q3 2020 Nov 16, 2020	SELL	$113.26 - $167.27 $408,189 - $602,841	-3,604 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $259,524 - $433,885	3,604 New	3,604 $411,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.